Wan Rabiah Wan Omar, Selva Rani John Jasudass, S. R. Saad
{"title":"马来西亚太平医院患者对三硝酸甘油舌下治疗的了解和使用情况","authors":"Wan Rabiah Wan Omar, Selva Rani John Jasudass, S. R. Saad","doi":"10.5281/ZENODO.1100183","DOIUrl":null,"url":null,"abstract":"Background: The objectives of this study were to \nassess patient’s knowledge of appropriate sublingual glyceryl \ntrinitrate (GTN) use as well as to investigate how patients commonly \nstore and carry their sublingual GTN tablets. Methodology: This was \na cross-sectional survey, using a validated researcher-administered \nquestionnaire. The study involved cardiac patients receiving \nsublingual GTN attending the outpatient and inpatient departments of \nTaiping Hospital, a non-academic public care hospital. The minimum \ncalculated sample size was 92, but 100 patients were conveniently \nsampled. Respondents were interviewed on 3 areas, including \ndemographic data, knowledge and use of sublingual GTN. Eight \nitems were used to calculate each subject’s knowledge score and six \nitems were used to calculate use score. Results: Of the 96 patients \nwho consented to participate, majority (96.9%) were well aware of \nthe indication of sublingual GTN. With regards to the mechanism of \naction of sublingual GTN, 73 (76%) patients did not know how the \nmedication works. Majority of the patients (66.7%) knew about the \nproper storage of the tablet. In relation to the maximum number of \nsublingual GTN tablets that can be taken during each angina episode, \n36.5% did not know that up to 3 tablets of sublingual GTN can be \ntaken during each episode of angina. Fifty four (56.2%) patients were \nnot aware that they need to replace sublingual GTN every 8 weeks \nafter receiving the tablets. Majority (69.8%) of the patients \ndemonstrated lack of knowledge with regards to the use of sublingual \nGTN as prevention of chest pain. Conclusion: Overall, patients’ \nknowledge regarding the self-administration of sublingual GTN is \nstill inadequate. The findings support the need for more frequent \nreinforcement of patient education, especially in the areas of \npreventive use, storage and drug stability.","PeriodicalId":23673,"journal":{"name":"World Academy of Science, Engineering and Technology, International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering","volume":"6 1","pages":"758-761"},"PeriodicalIF":0.0000,"publicationDate":"2015-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient’s Knowledge and Use of Sublingual Glyceryl Trinitrate Therapy in Taiping Hospital, Malaysia\",\"authors\":\"Wan Rabiah Wan Omar, Selva Rani John Jasudass, S. R. Saad\",\"doi\":\"10.5281/ZENODO.1100183\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The objectives of this study were to \\nassess patient’s knowledge of appropriate sublingual glyceryl \\ntrinitrate (GTN) use as well as to investigate how patients commonly \\nstore and carry their sublingual GTN tablets. Methodology: This was \\na cross-sectional survey, using a validated researcher-administered \\nquestionnaire. The study involved cardiac patients receiving \\nsublingual GTN attending the outpatient and inpatient departments of \\nTaiping Hospital, a non-academic public care hospital. The minimum \\ncalculated sample size was 92, but 100 patients were conveniently \\nsampled. Respondents were interviewed on 3 areas, including \\ndemographic data, knowledge and use of sublingual GTN. Eight \\nitems were used to calculate each subject’s knowledge score and six \\nitems were used to calculate use score. Results: Of the 96 patients \\nwho consented to participate, majority (96.9%) were well aware of \\nthe indication of sublingual GTN. With regards to the mechanism of \\naction of sublingual GTN, 73 (76%) patients did not know how the \\nmedication works. Majority of the patients (66.7%) knew about the \\nproper storage of the tablet. In relation to the maximum number of \\nsublingual GTN tablets that can be taken during each angina episode, \\n36.5% did not know that up to 3 tablets of sublingual GTN can be \\ntaken during each episode of angina. Fifty four (56.2%) patients were \\nnot aware that they need to replace sublingual GTN every 8 weeks \\nafter receiving the tablets. Majority (69.8%) of the patients \\ndemonstrated lack of knowledge with regards to the use of sublingual \\nGTN as prevention of chest pain. Conclusion: Overall, patients’ \\nknowledge regarding the self-administration of sublingual GTN is \\nstill inadequate. The findings support the need for more frequent \\nreinforcement of patient education, especially in the areas of \\npreventive use, storage and drug stability.\",\"PeriodicalId\":23673,\"journal\":{\"name\":\"World Academy of Science, Engineering and Technology, International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering\",\"volume\":\"6 1\",\"pages\":\"758-761\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Academy of Science, Engineering and Technology, International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5281/ZENODO.1100183\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Academy of Science, Engineering and Technology, International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/ZENODO.1100183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Patient’s Knowledge and Use of Sublingual Glyceryl Trinitrate Therapy in Taiping Hospital, Malaysia
Background: The objectives of this study were to
assess patient’s knowledge of appropriate sublingual glyceryl
trinitrate (GTN) use as well as to investigate how patients commonly
store and carry their sublingual GTN tablets. Methodology: This was
a cross-sectional survey, using a validated researcher-administered
questionnaire. The study involved cardiac patients receiving
sublingual GTN attending the outpatient and inpatient departments of
Taiping Hospital, a non-academic public care hospital. The minimum
calculated sample size was 92, but 100 patients were conveniently
sampled. Respondents were interviewed on 3 areas, including
demographic data, knowledge and use of sublingual GTN. Eight
items were used to calculate each subject’s knowledge score and six
items were used to calculate use score. Results: Of the 96 patients
who consented to participate, majority (96.9%) were well aware of
the indication of sublingual GTN. With regards to the mechanism of
action of sublingual GTN, 73 (76%) patients did not know how the
medication works. Majority of the patients (66.7%) knew about the
proper storage of the tablet. In relation to the maximum number of
sublingual GTN tablets that can be taken during each angina episode,
36.5% did not know that up to 3 tablets of sublingual GTN can be
taken during each episode of angina. Fifty four (56.2%) patients were
not aware that they need to replace sublingual GTN every 8 weeks
after receiving the tablets. Majority (69.8%) of the patients
demonstrated lack of knowledge with regards to the use of sublingual
GTN as prevention of chest pain. Conclusion: Overall, patients’
knowledge regarding the self-administration of sublingual GTN is
still inadequate. The findings support the need for more frequent
reinforcement of patient education, especially in the areas of
preventive use, storage and drug stability.